Drug companies have many tactics as their disposal to minimize supply chain disruptions for critical healthcare products, but should they shoulder all of the costs of doing so?
Amazon is rumored to have taken measures to enter the pharmacy supply chain market. Can it be successful in pulling off yet another disruption?
A digitized supply chain in pharma has unfortunately failed to mitigate the growing opioid crisis in America. Can it and will it?
Pharmaceutical companies are transitioning to continuous flow manufacturing, using digital technologies to deliver consistent quality at lower costs
The US Food and Drug Administration (FDA) takes steps to protect against threats to the pharmaceutical supply chain posed by extreme weather events.
Pfizer is using digitalization to increase visibility and efficiency across its supply chain. But can the pharmaceutical giant capitalize on these benefits quickly enough?
With 91 Americans dying every day from opioid overdose and a fragmented pharmaceutical supply chain, a new company is leveraging technology to trace drugs from manufacturer to patient.
Startup PillPack shows us how drug-dispensing robots and textable pharmacists can provide peace of mind at no extra cost to customers.
Can wearables and electronic data capture (EDC) technologies improve clinical trials and accelerate new drug approval?
How the drug discovery process is keeping up with technology that outpaces Moore’s Law